NCT01169090View on ClinicalTrials.gov

A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

620

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

SK-0403

SK-0403

DRUG

Placebo

Placebo

DRUG

Sitagliptin

Sitagliptin

Trial Locations (40)

Unknown

Birmingham

Huntsville

Muscle Shoals

Phoenix

Encinitas

Huntington Park

Los Angeles

San Mateo

Spring Valley

Walnut Creek

Miami

Palm Harbour

Pembroke Pines

Honolulu

Chicago

Indianapolis

Lexington

Paducah

New Orleans

Saint Paul

Charlotte

Greenville

Statesville

Cincinnati

Marion

Mount Giliad

Oklahoma City

Eugene

Portland

Beaver

Charleston

Greensboro

Corpus Christi

Dallas

Houston

San Antonio

Salt Lake City

Sandy City

Norfolk

Richmond

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY